Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001789886-22-000001
Filing Date
2022-12-09
Accepted
2022-12-09 12:50:27
Documents
1
Effectiveness Date
2022-12-09
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6042
  Complete submission text file 0001789886-22-000001.txt   7143
Mailing Address 8200 HWY 100 NASHVILLE TN 37221
Business Address 8200 HWY 100 NASHVILLE TN 37221 6154981887
Curex Life Science Fund, LP (Filer) CIK: 0001789886 (see all company filings)

IRS No.: 843040522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-355687 | Film No.: 221454217